You must select a location to proceed.
There was a problem adding this course to your account. Please try again in a few minutes. If the problem persists, you can contact our support department at (877) 880-1335.
Adding Registration, Please wait...
You must be logged in to perform this action.
Prescribing Controlled Substances for MD/DO Prescribers
The required course for DEA-registered prescribers in Florida
THIS COURSE IS FOR MD/DO PHYSICIANS ONLY
PLEASE BE ADVISED THAT YOU WILL HAVE 90 DAYS TO COMPLETE THIS COURSE FROM THE DATE OF PURCHASE
On March 19, 2018, Gov. Rick Scott signed bill HB 21 into law which includes a variety of measures to combat the opioid crisis. The bill states that each person registered with the United States Drug Enforcement Administration and authorized to prescribe controlled substances shall complete a board-approved two-hour continuing education (CE) course on prescribing controlled substances. The Florida Medical Association (FMA) is authorized by HB 21 to provide this two-hour mandatory requirement for MDs and DOs. Although only DEA-registered prescribers of controlled substances are actually required to complete this training every two years, all physicians are welcome to complete this course. All CME credit earned will be reported to CE Broker. HB 21 requires prescribers to complete this course for the first time no later than January 31, 2019 and then for each subsequent renewal thereafter.
After completing this activity, learners will be able to:
- Recognize the relevant prescribing laws and rules that govern prescribers of controlled substances in Florida
- Compare and contrast scheduled drugs related to treatment of pain, both acute and chronic nonmalignant pain
- List alternative pharmacologic options, non-pharmacologic methods and procedures, and complementary and alternative treatment options for managing pain
- Apply concepts of SBIRT (screening, brief intervention and referral to treatment) and motivational interviewing within patient encounters
- Utilize appropriate screening tools such as ORT®, SOAPP-R®, COMM™, UDS, E-FORCSE® and others to identify patients at risk for misuse or who are addicted to controlled substances
- Implement appropriate monitoring and referrals for patients who are prescribed controlled substances
- List appropriate screening and documentation requirements for prescribing controlled substances in patients experiencing pain
- State national recommendations on the safe levels of opioids by morphine milligram dose equivalents and durations of treatment for acute and chronic nonmalignant pain
Disclosure: The planners of this activity have nothing to disclose and the presenter has nothing to disclose.
Estimated Completion Time: Two Hours
Instructions for Earning Credit:
- Read and review the entire document in full or in parts until completed.
- Reflect on the current and best practices discussed and how the information may change your own current practices.
- Use the practice cases to challenge your understanding of the new Florida laws or clinical practice guidelines.
- Complete the knowledge assessment/post-test (must earn a passing score of at least 73%) AND the evaluation.
- For incorrect responses on the post-test, revisit areas of the document to strengthen your understanding of the question.
Issue Date: October 5, 2018
Expiration Date: October 1, 2021
|2 AMA PRA Category 1 Credits™ (Enduring Material)
The Florida Medical Association is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education activities for physicians.
The Florida Medical Association designates this enduring material for a maximum of 2 AMA PRA Category 1 Credits™.
Physicians should claim only those credits commensurate with the extent of their participation in the activity.